Pleurodesis by erythromycin, tetracycline, AerosilTM 200, and erythromycin plus AerosilTM 200 in a rat model: a preliminary study

Journal Title: DARU Journal of Pharmaceutical Sciences - Year 2012, Vol 20, Issue 0

Abstract

Background None of the current pleurodesing agents fulfil all the criteria for best pleural sclerosant. Therefore, the search for the ideal agent for chemical pleurodesis still continues. The aim of the present study was to compare the effectiveness of erythromycin, tetracycline, AerosilTM 200 (hydrophilic fumed amorphous silica), and erythromycin plus AerosilTM 200 in producing pleurodesis in rats. In the present study, talc was not used as a pleurodesing agent due to an unavailability of its sterile and pure form in Iran. Methods Overall, 75 adult male Spraque-Dawley rats were randomized to 5 treatment groups. Each group received an intrapleural injection via 5 Fr Silastic tubes of one of the following sterile agents: 35mg/kg erythromycin in 2 ml of saline, 35mg/kg tetracycline in 2 ml of saline, 35mg/kg AerosilTM 200 in 2ml of saline, erythromycin (35mg/kg in 2 ml of saline) plus AerosilTM 200 (35mg/kg in 2 ml of saline), or 2 ml of saline as a control. The animals were euthanized and necropsied 30 days after injection. The pleurae were assessed for macroscopic and microscopic evidence of surrounding inflammation and fibrosis. Results The median macroscopic score in the AerosilTM 200 group was significantly higher than that in the erythromycin group (P < 0.005). The median microscopic score in the erythromycin group was significantly lower than that in the AerosilTM 200 and erythromycin plus AerosilTM 200 groups (P < 0.005). Furthermore, maximum and minimum pleural fibrosis was observed in the erythromycin plus AerosilTM 200 and erythromycin groups, respectively (P < 0.05). Conclusion This study suggests that AerosilTM 200 with or without erythromycin may be more potent pleurodesis agent than erythromycin and tetracycline.

Authors and Affiliations

Shahryar Hashemzadeh, Khosrow Hashemzadeh, Kamran Mamaghani, Elnaz Ansari, Raheleh Aligholipour, Samad EJ Golzari , Kamyar Ghabili

Keywords

Related Articles

Drying of a plasmid containing formulation: chitosan as a protecting agent

Along with research on development of more efficient gene delivery systems, it is necessary to search on stabilization processes to extend their active life span. Chitosan is a nontoxic, biocompatible and available gene...

Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia

IntroductionImmune thrombocytopenia (ITP) is an immune disorder commonly presents as isolated thrombocytopenia. Generally corticosteroids are the main treatment of ITP. This study was designed to evaluate effectiveness o...

In vitro alpha-glucosidase inhibitory activity of phenolic constituents from aerial parts of Polygonum hyrcanicum

Background and the purpose of the study The early stage of diabetes mellitus type 2 is associated with postprandial hyperglycemia. Hyperglycemia is believed to increase the production of free radicals and reactive oxygen...

Application of nanomedicine in emergency medicine; A point-of-care testing and drug delivery in twenty first century

The application of emerging nanotechnology to the practice of medicine represents a frontier of nanomedicine. Nanomedicine has been defined as a science which emphasizes the use of nanoscale tools in conjunction with bac...

Download PDF file
  • EP ID EP92924
  • DOI -
  • Views 145
  • Downloads 0

How To Cite

Shahryar Hashemzadeh, Khosrow Hashemzadeh, Kamran Mamaghani, Elnaz Ansari, Raheleh Aligholipour, Samad EJ Golzari, Kamyar Ghabili (2012). Pleurodesis by erythromycin, tetracycline, AerosilTM 200, and erythromycin plus AerosilTM 200 in a rat model: a preliminary study. DARU Journal of Pharmaceutical Sciences, 20(0), 1-13. https://europub.co.uk/articles/-A-92924